Chronic Renal Allograf Rejection. Part II. Possibilities of Therapy
Authors:
O. Viklický; I. Matl; J. Lácha
Authors‘ workplace:
Klinika nefrologie - Transplantační centrum IKEM, Praha 1 Semmelweisova Universita, Budapešť, Maďarsko 2 Nefrologické oddělení, Univerzitní klinika, Essen, SRN
Published in:
Čas. Lék. čes. 2000; : 524-528
Category:
Overview
Chronic rejection represents an important cause of renal allograft loss in the long term follow up. New insightsinto etiopathogenesis of the chronic rejection offer possibilities for experimental therapy. Novel immunosuppressants,such as mycophenolic acid, tacrolimus or rapamycin as well as lipid lowering drugs, angiotensin-converting enzymeinhibitors or AT-1 receptor blockers, may reduce of effects the risk factors on the progression of chronic rejection.In the future, gene therapy may offer additional possibilities to prevent chronic rejection. This review deals withpossibilities of prevention of the chronic renal allograft rejection based on experimental evidences and currenttherapeutic concepts and puts these options into a rational perspective.
Key words:
renal transplantation, chronic rejection, experimental therapy, immunosuppression.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
Most read in this issue
- Development of the Abdominal and Gluteal (Waist and Hip) Circumferences in Adulthood
- Dendritic Cells and the Immunotherapy of Tumors
- Final Height of Patients Following Long-Term Treatment for theIdiopathic Growth Hormone Deficiency (The Czech Register 1991-1998)
- Chronic Renal Allograf Rejection. Part II. Possibilities of Therapy